Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455416
Status:
UNKNOWN
Last Update Posted:
2008-05-21
First Post:
2007-04-02
Brief Title:
Dietary Intervention in Follicular Lymphoma
Sponsor:
Oslo University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
Dietary Intervention in Stage IIIIV Follicular Lymphoma Impact on Markers of Cell Proliferation Apoptosis Host Immune Cell Infiltrate and Oxidative Stress
Status:
UNKNOWN
Status Verified Date:
2007-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KLYMF
Brief Summary:
A dietary intervention study in patients with Follicular Lymphoma FL Stage IIIIV to assess the ability of several dietary factors to induce apoptosis inhibit cell proliferation and modulate tumor cell infiltrate in vivo
Detailed Description:
Dietary factors plays an important role in the prevention of several diseases The cardiovascular disease mortality have dropped dramatically the last 20 years but the relative death rates from cancer remains fairly stable There is reason to believe that factors in the tumors microenvironment is of great importance for the outcome of many malignant diseases including FL Factors predicting a poor outcome are associated with inflammation oxidative stress which both impair the hosts immune response and produces growth stimulatory signals In this open study with 45 patients to be included we seek to perform a dietary intervention with comparison of apoptosis rate proliferation rate and immune cell infiltrate before and after the intervention period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None